Andrew Maynard
Andrew Maynard
Director of the Risk Innovation Lab, Arizona State University
Dirección de correo verificada de asu.edu - Página principal
Título
Citado por
Citado por
Año
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study
CA Poland, R Duffin, I Kinloch, A Maynard, WAH Wallace, A Seaton, ...
Nature nanotechnology 3 (7), 423, 2008
26582008
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
G Oberdörster, A Maynard, K Donaldson, V Castranova, J Fitzpatrick, ...
Particle and fibre toxicology 2 (1), 8, 2005
21372005
Safe handling of nanotechnology
AD Maynard, RJ Aitken, T Butz, V Colvin, K Donaldson, G Oberdörster, ...
Nature 444 (7117), 267-269, 2006
16212006
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice
AA Shvedova, ER Kisin, R Mercer, AR Murray, VJ Johnson, AI Potapovich, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 289 (5 …, 2005
14462005
Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells
A Shvedova, V Castranova, E Kisin, D Schwegler-Berry, A Murray, ...
Journal of toxicology and environmental health Part A 66 (20), 1909-1926, 2003
14252003
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system
A Elder, R Gelein, V Silva, T Feikert, L Opanashuk, J Carter, R Potter, ...
Environmental health perspectives 114 (8), 1172-1178, 2006
10822006
Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material
AD Maynard, PA Baron, M Foley, AA Shvedova, ER Kisin, V Castranova
Journal of Toxicology and Environmental Health, Part A 67 (1), 87-107, 2004
9102004
Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis
AA Shvedova, E Kisin, AR Murray, VJ Johnson, O Gorelik, S Arepalli, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 295 (4 …, 2008
6422008
Airborne nanostructured particles and occupational health
AD Maynard, ED Kuempel
Journal of nanoparticle research 7 (6), 587-614, 2005
6282005
Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles
JS Tsuji, AD Maynard, PC Howard, JT James, C Lam, DB Warheit, ...
Toxicological sciences 89 (1), 42-50, 2006
5312006
Nanotechnology: the next big thing, or much ado about nothing?
AD Maynard
The Annals of occupational hygiene 51 (1), 1-12, 2007
3962007
The new toxicology of sophisticated materials: nanotoxicology and beyond
AD Maynard, DB Warheit, MA Philbert
Toxicological sciences 120 (suppl_1), S109-S129, 2011
3382011
Nanotechnology: a research strategy for addressing risk
AD Maynard
3202006
Meeting report: hazard assessment for nanoparticles—report from an interdisciplinary workshop
JM Balbus, AD Maynard, VL Colvin, V Castranova, GP Daston, ...
Environmental Health Perspectives 115 (11), 1654-1659, 2007
2972007
Assessing exposure to airborne nanomaterials: current abilities and future requirements
AD Maynard, RJ Aitken
Nanotoxicology 1 (1), 26-41, 2007
2932007
Ultrafine particles: mechanisms of lung injury
K Donaldson, V Stone, PS Gilmour, DM Brown, W MacNee
Philosophical Transactions of the Royal Society of London. Series A …, 2000
2822000
Nanotechnology: assessing the risks
AD Maynard
Nano today 1 (2), 22-33, 2006
2672006
A survey of wind speeds in indoor workplaces
PEJ Baldwin, AD Maynard
The Annals of occupational hygiene 42 (5), 303-313, 1998
2611998
Don't define nanomaterials
AD Maynard
Nature 475 (7354), 31-31, 2011
1542011
Health risk assessment for nanoparticles: A case for using expert judgment
M Kandlikar, G Ramachandran, A Maynard, B Murdock, WA Toscano
Journal of Nanoparticle Research 9 (1), 137-156, 2007
1482007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20